Styptic composition
US4166108A · kind A · utility
Inventors
Key dates
| Filing date | Aug 18, 1977 |
| Grant date | Aug 28, 1979 |
| Priority date | — |
| Expiry date | Aug 18, 1997 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/05
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An improved styptic composition which effectively curtails bleeding while administering a soothing sensation on the injured area. The styptic composition is in the form of a stable lotion or cream having the following general formula: PA1 (1) from about 2% to about 12% by weight of a long chain fatty acid; PA1 (2) from about 0.4% to about 3.5% by weight of a wax filler; PA1 (3) from about 1% to about 10% by weight of polyethylene glycol stearate; PA1 (4) from about 1% to about 5% by weight of polyethylene glycol sorbitan beeswax; and, PA1 (5) from about 0.5% to about 25% by weight of an acidic metallic salt, PA1 (6) the balance being water. Optionally, from about 1% to about 4% by weight of glycerin may be added as a humectant. Any conventional antiseptic may also be added to the composition. The styptic composition may be packaged in any convenient form including jars, bottles, tubes, pump applicators, aerosol canisters and can also be impregnated into pre-packaged bandages.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.